These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16935690)

  • 1. Pharmacological management of mild or moderate persistent asthma.
    O'Byrne PM; Parameswaran K
    Lancet; 2006 Aug; 368(9537):794-803. PubMed ID: 16935690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
    N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide/formoterol maintenance and reliever therapy versus conventional best practice.
    Demoly P; Louis R; Søes-Petersen U; Naya I; Carlsheimer A; Worth H; Almeida J; Sears MR
    Respir Med; 2009 Nov; 103(11):1623-32. PubMed ID: 19762222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [symbol: see text] Seretide and [symbol: see text] Symbicort in asthma management.
    Drug Ther Bull; 2002 Aug; 40(8):62-4. PubMed ID: 12216339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
    Rabe KF; Atienza T; Magyar P; Larsson P; Jorup C; Lalloo UG
    Lancet; 2006 Aug; 368(9537):744-53. PubMed ID: 16935685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
    Ceylan E; Gencer M; Aksoy S
    Respiration; 2004; 71(6):594-601. PubMed ID: 15627870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
    Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG
    Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma.
    Patel YA; Patel P; Bavadia H; Dave J; Tripathi CB
    J Postgrad Med; 2010; 56(4):270-4. PubMed ID: 20935397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing a variable disease.
    Kips J
    Pulm Pharmacol Ther; 2002; 15(6):485-90. PubMed ID: 12493334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
    Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
    Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic interventions to reduce the risk of asthma exacerbations.
    O'Byrne PM
    Proc Am Thorac Soc; 2004; 1(2):105-8. PubMed ID: 16113421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark--cost-effectiveness analysis based on five randomised controlled trials.
    Wickstrøm J; Dam N; Malmberg I; Hansen BB; Lange P
    Clin Respir J; 2009 Jul; 3(3):169-80. PubMed ID: 20298400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?
    Sovani MP; Whale CI; Oborne J; Cooper S; Mortimer K; Ekström T; Tattersfield AE; Harrison TW
    Br J Gen Pract; 2008 Jan; 58(546):37-43. PubMed ID: 18186995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
    Buhl R; Vogelmeier C
    Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.